Mobile

A study in which patients will be assigned, by chance, to receive either the active drug Praluent or a dummy-drug, (a placebo), without anybody knowing what that are assigned to, to determine if there...

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-003189-16

A study in which patients will be assigned, by chance, to receive either the active drug Praluent or a dummy-drug, (a placebo), without anybody knowing what that are assigned to, to determine if there is any effect on memory and reaction time, (known as Neurocognitive Function), when taking Praluent, in Patients with high cholesterol with high and very high risk for heart and blood vessel diseases

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to evaluate neurocognitive function with use of Praluent after 96 weeks of treatment versus placebo

Critère d'inclusion

  • Heterozygous Familial Hypercholesterolemia or Non-Familial Hypercholesterolemia with High and Very High Cardiovascular Risk

Liens